ACHE and chronic obstructive pulmonary disease: Although Lansoprazole and Tacrine show limited direct efficacy in COPD, their mechanisms of action, such as glutamate receptor modulation and acetylcholinesterase inhibition, highlight their indirect therapeutic benefits, warranting further investigation.